Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial. [PDF]
Lee CK +34 more
europepmc +1 more source
Nuclear effects play an important role in determining codon usage-dependent human gene expression. [PDF]
Garg R, Xie P, Duan J, Liu H, Liu Y.
europepmc +1 more source
Mechanisms of Immune Evasion, Dissemination, and Persistence in Leishmania amazonensis Infection. [PDF]
Portugal AB +3 more
europepmc +1 more source
Th7R predicts chemo-immunotherapy response and survival in small cell lung cancer. [PDF]
Takei S +9 more
europepmc +1 more source
Cytoplasmic poly-adenosine binding proteins modulate susceptibility of mRNAs to Pumilio-mediated decay. [PDF]
McKenney KM +6 more
europepmc +1 more source
A historical review of mycosis fungoides: from Alibert to mogamulizumab. [PDF]
Johnson NA +4 more
europepmc +1 more source
The changing immune landscape of innate-like T cells and other innate cells throughout life. [PDF]
Taheri M +9 more
europepmc +1 more source
C-C chemokine receptor 4 deficiency exacerbates early atherosclerosis in mice. [PDF]
Tanaka T +9 more
europepmc +1 more source
CD8⁺ T cell heterogeneity in aging: insights from single-cell profiling. [PDF]
Filippov I, Peterson P.
europepmc +1 more source
Efficacy and tolerability of mogamulizumab in mycosis fungoides and Sézary Syndrome: a monocentric retrospective study. [PDF]
Giordano A +5 more
europepmc +1 more source

